Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway. [electronic resource]
Producer: 20200626Description: 1106-1121 p. digitalISSN:- 1476-5381
- Acute Kidney Injury -- drug therapy
- Animals
- Cell Line
- Humans
- Kidney -- drug effects
- MAP Kinase Signaling System -- drug effects
- Male
- Mice, Inbred C57BL
- Mice, Knockout
- NF-kappa B -- metabolism
- Protective Agents -- pharmacology
- Rhabdomyolysis -- complications
- Signal Transduction
- Toll-Like Receptor 4 -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.